Skip to main content Skip to main content

[Held on September 26th] The 29th Future of Surgery: AI Analysis of Soft Tissue Tumor Reconstruction and the Cutting Edge of Bone and Soft Tissue Tumor Surgery

[Held on September 26th] The 29th Future of Surgery: AI Analysis of Soft Tissue Tumor Reconstruction and the Cutting Edge of Bone and Soft Tissue Tumor Surgery

AI translated
Rare cancers Bone and soft tissue tumors Limb salvage surgery
Ended
2025 9/26 18:00 9/26 20:00 Japan Time
This seminar page
This seminar page

About this session

For the 29th "Future of Surgery" event, we are pleased to welcome Dr. Akira Kawai, Head of the Department of Bone and Soft Tissue Tumors and Rehabilitation at the National Cancer Center Hospital, to give a lecture on "The Cutting Edge and Future Prospects of Bone and Soft Tissue Tumor Surgery 2025: Challenges in Limb Preservation and Quality of Life Improvement."

Malignant bone and soft tissue tumors (sarcomas) are characterized by being both malignant tumors and musculoskeletal disorders. Therefore, their treatment requires both an oncological perspective (improvement of life prognosis) and a perspective of maintaining and improving motor function (improvement of ADL and QOL).

This lecture will introduce the cutting edge and future prospects of bone and soft tissue tumor surgery in addressing this challenge. Specifically, it will discuss the types of surgical treatments and limb-preserving procedures being performed for malignant bone and soft tissue tumors, which are difficult to standardize due to the diversity of the tumors themselves, variations in surgical site (limbs vs. trunk) and tissue (bone vs. soft tissue), and the absolute small number of cases, as well as the multidisciplinary approaches that support them.

Those interested in the challenges and future prospects of bone and soft tissue tumor surgery, as well as the latest findings in supermicrosurgery, are encouraged to participate.


We are accepting applications until the last minute, so please invite your friends and apply together.

We will be inviting Dr. Akira Kawai, Chief, Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, for a lecture titled "Frontiers and Future Perspectives in Orthopedic Oncology 2025: Challenges Toward Limb Salvage and Improvement of Quality of Life."

Malignant bone and soft tissue tumors (sarcomas) are unique in that they are not only malignant tumors but also musculoskeletal diseases. Therefore, treatment must focus on both an oncological perspective (improving life prognosis) and a functional perspective (maintaining and improving activities of daily living and quality of life).

In this lecture, Dr. Kawai will provide an overview of the forefront and future outlook of orthopedic oncology surgery in addressing these challenges. He will discuss the surgical treatments and limb salvage procedures performed for malignant bone and soft tissue tumors. These procedures are particularly complex due to the diversity of tumors, variations in surgical sites (limbs vs. trunk) and tissues (bone vs. soft tissue), and the small number of cases. Dr. Kawai will also touch on the multidisciplinary approaches that support these treatments.

This is a must-attend event for anyone interested in the challenges and future prospects of orthopedic oncology surgery and the latest knowledge in supermicrosurgery.

Applications are accepted until the last minute, so please feel free to invite your colleagues and register.

Translated by Gemini.

Rare cancers Bone and soft tissue tumors Limb salvage surgery

Program

セミナー
AI analysis of reconstructive surgery for soft tissue tumors
icon
光嶋 勲
Koshima Isao
次世代スーパーマイクロサージャリー国際フォーラム 会長
東京大学 名誉教授
The Next-Generation of Super Mirosurgery International Forum
icon
Isao Koshima
President, The Next-Generation Super Microsurgery International Forum chairman
The University of Tokyo Professor Emeritus

"AI Analysis of Reconstructive Surgery for Soft Tissue Tumors"

"AI analysis of reconstructive surgery for soft tissue tumors"

セミナー
Frontiers and Future Perspectives in Orthopaedic Oncology 2025: Challenges Toward Limb Salvage and Improvement of Quality of Life
icon
川井 章
国立がん研究センター中央病院 骨軟部腫瘍・リハビリテーション科 科長
icon
Akira Kawai
National Cancer Center Hospital Department of Musculoskeletal Oncology and Rehabilitation Medicine Chief

"The Cutting Edge and Future Prospects of Bone and Soft Tissue Tumor Surgery 2025: Challenges in Limb Preservation and Quality of Life Improvement"

Malignant bone and soft tissue tumors (sarcomas) are characterized by being both malignant tumors and musculoskeletal diseases. In treating them, an oncological perspective (improvement of life prognosis) and a perspective of maintaining and improving motor function (improvement of ADL and QOL) are indispensable. In this lecture, I would like to introduce the forefront and future prospects of bone and soft tissue tumor surgery in addressing this challenge. Specifically, given the diversity of the tumors themselves, the variations in surgical sites (limbs vs. trunk) and tissues (bone vs. soft tissue), and the absolute small number of cases, it is difficult to standardize surgical procedures for malignant bone and soft tissue tumors. I would like to introduce the types of surgical treatments and limb-preserving surgeries performed at one of Japan's leading high-volume centers in collaboration with various surgical departments, including plastic surgery, and discuss the multidisciplinary approach that supports them.

"Frontiers and Future Perspectives in Orthopedic Oncology 2025:

Challenges Toward Limb Salvage and Improvement of Quality of Life"

Malignant bone and soft tissue tumors (sarcomas) are unique in that they are not only malignant tumors but also musculoskeletal diseases. Therefore, treatment must address both an oncological perspective (improving life prognosis) and the need to maintain and improve motor function (enhancing ADL and QOL).
This lecture will cover the forefront and future outlook of orthopedic oncology surgery in resolved these challenges. Specifically, we will discuss the surgical treatments and limb salvage procedures performed at a high-volume center, in collaboration with various surgical departments, including plastic surgery. We will also explore the multidisciplinary approach that supports these treatments, which are particularly complex due to the diversity of tumors, variations in surgical sites (limbs vs. trunk) and tissues (bone vs. soft tissue), and the small number of cases, all of which make it difficult to standardize surgical procedures.

Translated by Gemini.

This seminarShare

Please share it with anyone who might be interested.

LINE LinkedIn

PR

PR PR
SPONSORED
一般社団法人みらいメドテック
More
PR PR
SPONSORED
一般社団法人日本医工ものづくりコモンズ
More
PR PR
SPONSORED
ソニア・セラピューティクス株式会社
More
PR PR
SPONSORED
ソニア・セラピューティクス株式会社
More

[Held on September 26th] The 29th Future of Surgery: AI Analysis of Soft Tissue Tumor Reconstruction and the Cutting Edge of Bone and Soft Tissue Tumor Surgery

Please select a ticket
Tickets
Price